Treatment with DPPG₂-TSL-DOX combined with intravesical HT outperformed systemic and intravesical DOX in vivo. There might be a role for DPPG₂₋TSL encapsulating chemotherapeutics in the treatment of MIBC in the future.
No takes yet. Share an insight, caveat, or question.
Brummelhuis et al. (2021) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: